Thorleif Møller
Chief Executive Officer and Founder
Thorleif Møller is the inventor of the Blockmir technology upon which Mirrx Therapeutics is founded. Thorleif Møller holds a Ph.D in molecular biology and has worked extensively with RNA biology and RNA-based gene regulation. Among others, he discovered and characterized a central mechanism of promiscuous RNA-based gene regulation in bacteria. Thorleif Møller has worked as an IP-consultant for more than 5 years and has major experience within ip protection of new technologies. Mirrx Therapeutics is the second venture-backed company founded by Thorleif Møller.
